Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Oyster Point Pharma, Inc.

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST VTRS
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST VTRS
Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA®
From Oyster Point Pharma, Inc.
Via GlobeNewswire
Tickers OYST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.